Evidence – Engineering More Clinically Relevant Tumour Models to Evaluate Intratumoral Delivery & Turn Cold Tumours Hot
4:40 pm - Wednesday 2nd December 2026
- Exploring how tumour models can better replicate the practical realities of intratumoral dosing, distribution, and therapeutic exposure within solid tumours
- Evaluating strategies to optimise local delivery, injection approaches, and formulation design to maintain drug stability and activity within the tumour microenvironment
- Sharing future plans from the SPARC consortium on developing scalable approaches, including tumour on chips, to convert immunologically cold tumours into hot tumours that are responsive to antibody and immune-based therapies
